This site is part of the Informa Connect Division of Informa PLC

这个网站是由一个商业或企业owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe 2020 Event Timeline

BIO-Europe® Digital will beso much morethan scheduled virtual partnering meetings, recorded content, some live sessions and virtual networking opportunities during the week of October 26–29.

How would you like to see pre-recorded pitches by companies you may want to schedule one-to-one meetings with, available on demand five weeks before the event?

Sponsor and Showcase Company content will be ready to watch five weeks ahead of the conference, and you’ll be able to tune in on demand to panels on BD&L, Finance, Therapeutic Areas and up-to-the-minute Spotlight topics released weekly up until BIO-Europe officially opens.

Onemust-attend partnering event—and so much more!

Pre-released content to registered attendees

Please review the information below to learn more about the digital event and what content is available.

If you are not registered, be sure to register today to receive your partneringONE login and unlock the available content.

Showcase and Company pitches



  • Showcase content now available.
  • Company pitches available to watch on demand.
  • New search functionality launches.

Hear more from our very own Katharina Schropp and Santa Munro

New Program Content By Track


Business Development Track

  • Changing the game for external innovation and partnering at Bayer, a conversation with Dr. Marianne De Backer, Global Head, Business Development and Licensing
  • In conversation with Husseini Manji, Global Head, Science for Minds, Johnson % Johnson Innovation
  • Anatomy of a deal: Amgen and Neuvolution

Biotech Ecosystem Track

  • AGC Biologics Capabilities and the introduction of Cell & Gene Therapy

Hear more from our very own Claire Macht

NEW PROGRAM CONTENT BY TRACK


Business Development Track

  • Formulating an R&D vision at Servier, a conversation with Claude Bertrand, SVP, Head of R&D, Servier
  • Strategic collaboration with clients and value enhancing partners: the why, what and how with Federico Pollano, Senior VP, Business Development, Rentschler Biopharma SE

Spotlight Track

  • Korea’s Rising Bio Stars
  • Navigating Korea's investment and ecosystem to connect global bio-pharma
  • Ride the new wave in Korea’s pharmaceutical industry

Hear more from our very own Susanna Ling

Startup Slam, sponsored by Johnson & Johnson Innovation


  • Visit the Startup Slam section on partneringONE to hear welcome messages from this year’s Startup Slam judges: Juliette Audet- Principal at Forbion, Leonildo Delgado- Manager, Innovation and Sourcing at BaseLaunch, Elena Fernandez-Kleinlein- Head of JLABS EMEA Johnson & Johnson Innovation, Simon Kerry- Operating Partner at Advent Life Sciences, and Sunil Shah-CEO at o2h Group.

NEW PROGRAM AND NETWORKING OPPORTUNITIES


The Startup Slam sponsored by Johnson & Johnson:

  • The eight finalist pitches are posted to the Startup Slam page on partneringONE in advance of the live session on Tuesday, October 27, 15:00-16:00 CET.

Panel discussions on:

  • What a pandemic has taught us about digital health
  • The future of biotech investment
  • New tools to conquer chronic kidney disease
  • The repercussions of manufacturing requirements on cell and gene therapy deals

Fireside chats,Pitches and more!


Free Webinar: Re-imagining partnering events in digital times
Free Webinar: Re-imagining partnering events in digital times

Watch this webinar, hosted by Pam Putz, Managing Director of EBD Group Europe, to understand how BIO-Europe will provide the same high value as usual, transformed and improved for the digital age.

Watch Webinar
Event Conference Guide
Event Conference Guide

Take a look at all that this year's digital event has to offer you.

View conference guide

Tony Jones PhD

Chief Executive Officer

One Nucleus

Covid-19 has highlighted the enormous strengths of being a global industry. International collaboration at such scale is helping to develop vaccines and therapeutics at unprecedented and whilst the global nature appeared to be a perceived weakness initially as travel and conferences ceased, it has shown this is can be largely mitigated through the use of technology and online partnering. The vital role BIO-Europe plays in bringing international deal makers together at scale, digitally when required, is the reason it is a key event in the global Biopharma industry calendar